Page 86 - Looking Statement News Today

Share this article HOLON, Israel, March 9, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the publication of a review article titled "Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis" reviewing the biology and therapeutic relevance of the DNAM-1 axis in cancer immunotherapy. The peer-reviewed article, published in Cancer Discovery, a journal of the American Assoc...

Eltek Announces Receipt of a Grant from the Israel Investment Authority and Approval for Participation in a Special R&D Program Funded by the Israel Innovation Authority USA - English Share this article Share this article PETACH-TIKVA, Israel, March 8, 2021 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, today provided an update regarding its award of a grant from the Israeli Investment A...

Press release content from Business Wire. The AP news staff was not involved in its creation.

KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the bodys immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 KIRKLAND, QC, March 8, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Health Canada has approved KEYTRUDA ® (pembrolizumab), Mercks anti-PD-1 therapy, for the first...

Approval Based on Significant Progression Free Survival Findings from Phase 3 KEYNOTE-177 Trial KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the body’s immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2  Merck known as MSD outside the United States … Approval Based on Significant Progression Free Survival Findings from Pha...

(1) Expects to Lead to Increased Volume and Lower Costs LOS ANGELES, CA / ACCESSWIRE / March 5, 2021 / Pacific Ventures Group, Inc. (OTC PINK:PACV) (the "Company"), a food and beverage holding company specializing in the distribution of consumer food, beverage and alcohol-related products, is pleased to announce that it has purchased new machinery for its Seaport Meat Company operations. The addition of a Thompson Meat Grinder and a Roll Stock Machine will expand production capability and impro...

Share this article Share this article PHOENIX, March 4, 2021 /PRNewswire/ --Trutankless, Inc. (OTCQB: TKLS) manufactures an award-winning line of smart electric tankless water heaters. Trutankless announces it has completed the buildout of a new production laboratory and R&D facility. The newly renovated space located in Scottsdale is complete with state of the art research and testing systems for the development of new products. Trutankless has hired a prominent patent law firm and has filed t...

Search jobs Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK#MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations from its HIV clinical development programs that will be featured during the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), taking place virtually from March 6 – 10, 2021. Presentations will...

Merck known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority a division of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services … Merck (NYSE:MRK), known as MSD outside the United States and Canada, announ...

KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael T. Nally, chief marketing officer, is scheduled to participate in the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 p.m. EST.Investors, analysts, members o...